These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 732811)

  • 1. Amino acid conferred protection against melphalan: interference with leucine protection of melphalan cytotoxicity by the basic amino acids in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Mol Pharmacol; 1978 Nov; 14(6):1136-42. PubMed ID: 732811
    [No Abstract]   [Full Text] [Related]  

  • 2. Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Cancer Treat Rep; 1976 Sep; 60(9):1363-7. PubMed ID: 1016969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid-conferred protection against melphalan--characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells.
    Vistica DT; Toal JN; Rabinovitz M
    Biochem Pharmacol; 1978; 27(24):2865-70. PubMed ID: 736979
    [No Abstract]   [Full Text] [Related]  

  • 4. Amino acid conferred protection against melphalan: comparison of amino acids which reduce melphalan toxicity to murine bone marrow precursor cells (CFU-C) and murine L1210 leukemia cells.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1979 Jan; 23(1):171-83. PubMed ID: 441510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carrier mechanism and specificity accounting for the increase in intracellular melphalan by the basic amino acids.
    Vistica DT; Schuette BP
    Mol Pharmacol; 1981 Jan; 19(1):92-6. PubMed ID: 7207465
    [No Abstract]   [Full Text] [Related]  

  • 6. Cytotoxicity as an indicator for transport mechanism: evidence that melphalan is transported by two leucine-preferring carrier systems in the L1210 murine leukemia cell.
    Vistica DT
    Biochim Biophys Acta; 1979 Jan; 550(2):309-17. PubMed ID: 569503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-alpha-amino-gamma-guanidinobutyric acid on melphalan therapy of the L1210 murine leukemia.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 May; 6(6):345-50. PubMed ID: 455272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transport and cytotoxicity of amino acid nitrogen mustards: implications for the design of more selective antitumor agents.
    Vistica DT; Ahmad S; Fuller R; Hill J
    Fed Proc; 1986 Sep; 45(10):2447-2450. PubMed ID: 3743787
    [No Abstract]   [Full Text] [Related]  

  • 9. Amino acid conferred protection against melphalan interference with melphalan therapy by L-leucine, a competitive substrate for transport.
    Vistica DT; Rabon A; Rabinovitz M
    Cancer Lett; 1979 Jan; 6(1):7-13. PubMed ID: 544013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amphotericin B on adriamycin and melphalan cytotoxicity in human and murine ovarian carcinoma and in L1210 leukemia.
    Ozols RF; Hogan WM; Grotzinger KR; McCoy W; Young RC
    Cancer Res; 1983 Mar; 43(3):959-64. PubMed ID: 6825115
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement of melphalan therapy with glutaminase:asparaginase.
    Vistica DT; Rabon A; Rabinovitz M
    Res Commun Chem Pathol Pharmacol; 1978 Oct; 22(1):83-92. PubMed ID: 725323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of melphalan by sensitive and resistant L1210 cells.
    Redwood WR; Colvin M
    Cancer Res; 1980 Apr; 40(4):1144-9. PubMed ID: 7357545
    [No Abstract]   [Full Text] [Related]  

  • 13. Uptake of melphalan by human ovarian carcinoma cells and its relationship to the amino acid content of ascitic fluid.
    Vistica DT; Von Hoff DD; Torain B
    Cancer Treat Rep; 1981; 65(1-2):157-61. PubMed ID: 7226165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity as an indicator for transport mechanism: evidence that murine bone marrow progenitor cells lack a high-affinity leucine carrier that transports melphalan in murine L1210 leukemia cells.
    Vistica DT
    Blood; 1980 Sep; 56(3):427-9. PubMed ID: 7407411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiamine protection of murine L1210 leukemia cells against mechlorethamine cytotoxicity and its relation to the choline uptake system.
    Naujokaitis SA
    Res Commun Chem Pathol Pharmacol; 1981 May; 32(2):317-27. PubMed ID: 7244366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.
    Zwelling LA; Filipski J; Kohn KW
    Cancer Res; 1979 Dec; 39(12):4989-95. PubMed ID: 498125
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of DL-threo-beta-fluoroasparagine against human leukemia cells in culture and L1210 cells in DBA mice.
    Stern AM; Abeles RH; Tashjian AH
    Cancer Res; 1984 Dec; 44(12 Pt 1):5614-8. PubMed ID: 6498822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to melphalan as a function of transport activity and proliferative rate in BALB/c 3T3 fibroblasts.
    Blosmanis R; Wright JA; Goldenberg GJ
    Cancer Res; 1987 Mar; 47(5):1273-7. PubMed ID: 3815338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicities of the L and D isomers of phenylalanine mustard in L 1210 cells.
    Vistica DT; Rabon A; Rabinovitz M
    Biochem Pharmacol; 1979 Nov; 28(21):3221-5. PubMed ID: 526327
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies with 2,5-piperazinedione, 3,6-bis(5-chloro-2-piperidyl)-,dihydrochloride. III. Biochemical and therapeutic effects in L1210 leukemias sensitive and resistant to alkylating agents: comparison with melphalan, cyclophosphamide, and BCNU.
    Schabel FM; Trader MW; Laster WR; Shaddix SC; Brockman RW
    Cancer Treat Rep; 1976 Sep; 60(9):1325-33. PubMed ID: 1016968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.